Shelley Chu
Angel · Massachusetts
Verified active in the last 12 months
Board director at 8 startups that filed Form D raises since late 2024, mostly in Massachusetts.
- Stages
- Series A, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Dec 2025
Focus
Biotech & PharmaRecent portfolio activity
- Dec 2025
Triana Biomedicines
Board seat · MA
- Dec 2025
Protego Biopharma
Board seat · CA
- Mar 2025
Antares Therapeutics
Board seat · MA
- Aug 2024
Enlaza Therapeutics
Board seat · CA
- Jul 2024
Scorpion Therapeutics
Board seat · MA
- Dec 2023
Abata Therapeutics
Board seat · MA
- Dec 2023
Odyssey Therapeutics
Board seat · MA
- Dec 2023
Seismic Therapeutic
Board seat · MA
Sources
- SEC Form D: Seismic TherapeuticDec 4, 2023
- SEC Form D: Odyssey TherapeuticsDec 15, 2023
- SEC Form D: Abata TherapeuticsDec 27, 2023
- SEC Form D: Scorpion TherapeuticsJul 16, 2024
- SEC Form D: Enlaza TherapeuticsAug 9, 2024
- SEC Form D: Antares TherapeuticsMar 12, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.